NPCE Projected Dividend Yield

Neuropace Inc ( NASDAQ : NPCE )

Neuropace is a medical device company focused on transforming the lives of people with epilepsy. Co.'s RNS System is a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. By monitoring the brain's electrical activity, recognizing patient-specific abnormal electrical patterns, and responding in real time with imperceptible electrical pulses to prevent seizures, Co.'s RNS System is programmed by clinicians to deliver the amount of therapy when and where it is needed and provides exceptional clinical outcomes. Co.'s RNS System records brain activity data and allows clinicians to monitor patients not only in person, but also remotely.

20 YEAR PERFORMANCE RESULTS